|
Thrombosis risk factors
Citations 141-150 of 165 total displayed.
|
Past content
(since Dec 2000):
|
- Brief Rapid Communications
Lethal Perinatal Thrombosis in Mice Resulting From the Interaction of Tissue Factor Pathway Inhibitor Deficiency and Factor V Leiden
- Daniel T. Eitzman, Randal J. Westrick, Xiaoming Bi, Sara L. Manning, John E. Wilkinson, George J. Broze, and David Ginsburg
Circulation 2002;105:2139-2142; published online before print as doi:10.1161/01.CIR.0000017361.39256.82
[Abstract]
[Full text]
- Articles
Lethal Perinatal Thrombosis in Mice Resulting From
the Interaction of Tissue Factor Pathway Inhibitor
Deficiency and Factor V Leiden
- Daniel T. Eitzman, Randal J. Westrick, Xiaoming Bi, Sara L. Manning, John E. Wilkinson, George J. Broze, and David Ginsburg
Circulation published April 15, 2002, doi:10.1161/01.CIR.0000017361.39256.82
[Abstract]
- Editorials
Vitamin C, Collagen, and Cracks in the Plaque
- Peter Libby and Masanori Aikawa
Circulation 2002;105:1396-1398, doi:10.1161/01.CIR.0000012513.58079.EA
[Full text]
- Basic Science Reports
Sex Steroids Used in Hormonal Treatment Increase Vascular Procoagulant Activity by Inducing Thrombin Receptor (PAR-1) Expression: Role of the Glucocorticoid Receptor
- Olaf Herkert, Herbert Kuhl, Jurgen Sandow, Rudi Busse, and Valérie B. Schini-Kerth
Circulation 2001;104:2826-2831, doi:10.1161/hc4801.099737
[Abstract]
[Full text]
- Clinical Investigations and Reports
Low Plasma Levels of Vitamin B6 Are Independently Associated With a Heightened Risk of Deep-Vein Thrombosis
- M. Cattaneo, R. Lombardi, A. Lecchi, P. Bucciarelli, and P. M. Mannucci
Circulation 2001;104:2442-2446, doi:10.1161/hc4501.098925
[Abstract]
[Full text]
- Clinical Investigations and Reports
Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
- Marvin A. Konstam, Matthew R. Weir, Alise Reicin, Deborah Shapiro, Rhoda S. Sperling, Eliav Barr, and Barry J. Gertz
Circulation 2001;104:2280-2288; published online before print as doi:10.1161/hc4401.100078
[Abstract]
[Full text]
- Clinical Investigations and Reports
Oral Anticoagulation Thresholds
- Kathleen E. Brummel, Sara G. Paradis, Richard F. Branda, and Kenneth G. Mann
Circulation 2001;104:2311-2317, doi:10.1161/hc4401.098492
[Abstract]
[Full text]
- Clinical Investigations and Reports
Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
- Marvin A. Konstam, Matthew R. Weir, Alise Reicin, Deborah Shapiro, Rhoda S. Sperling, Eliav Barr, and Barry J. Gertz
Circulation published October 15, 2001, doi:10.1161/hc4401.100078
[Abstract]
[Full text]
- Brief Rapid Communications
Novel Platelet Membrane Glycoprotein VI Dimorphism Is a Risk Factor for Myocardial Infarction
- S. A. Croft, N. J. Samani, M. D. Teare, K. K. Hampton, R. P. Steeds, K. S. Channer, and M. E. Daly
Circulation 2001;104:1459-1463, doi:10.1161/hc3801.096397
[Abstract]
[Full text]
- Clinical Investigations and Reports
Oxidative Stress and Platelet Activation in Homozygous Homocystinuria
- G. Davì, G. Di Minno, A. Coppola, G. Andria, A. M. Cerbone, P. Madonna, A. Tufano, A. Falco, P. Marchesani, G. Ciabattoni, and C. Patrono
Circulation 2001;104:1124-1128, doi:10.1161/hc3501.095287
[Abstract]
[Full text]
|
|